Cladribine Combined with Low-Dose Cytarabine as Frontline Treatment for Unfit Elderly Acute Myeloid Leukemia Patients: Results from a Prospective Multicenter Study of Polish Adult Leukemia Group (PALG)
Bożena Katarzyna Budziszewska(Instytut Hematologii i Transfuzjologi), Ewa Lech‐Marańda(Instytut Hematologii i Transfuzjologi), Marzena Wątek(Holy Cross University), Agnieszka Pluta, Karol Wójcik, Aleksander Salomon‐Perzyński(Instytut Hematologii i Transfuzjologi), Agnieszka Wierzbowska(Medical University of Lodz), Grzegorz Charliński(Nicolaus Copernicus University), Anna Janowska(Medical University of Lodz), Agnieszka Piekarska(Gdańsk Medical University), Marek Hus(Medical University of Lublin), Sebastian Giebel(The Maria Sklodowska-Curie National Research Institute of Oncology), Bartosz Puła(Instytut Hematologii i Transfuzjologi), Mariola Sędzimirska, Łukasz Bołkuń(Medical University of Białystok), Edyta Cichocka(Nicolaus Copernicus University), Grzegorz Helbig(Medical University of Silesia), Sebastian Grosicki(Medical University of Silesia), Elżbieta Patkowska(Institute for Transfusion Medicine), Anna Irga-Staniukiewicz(Gdańsk Medical University), Marta Kuydowicz(Medical University of Lodz), Jarosław Piszcz(Medical University of Białystok), Małgorzata Raźny, Tomasz Gromek(Medical University of Lublin), Sylwia Kościołek-Zgódka(Lublin Oncology Center), Joanna Barankiewicz(Instytut Hematologii i Transfuzjologi), Katarzyna Pruszczyk(Instytut Hematologii i Transfuzjologi), P. Małecki(Medical University of Silesia), Jan Maciej Zaucha(Gdańsk Medical University)
Cited by 11
Related Papers
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
|Blood|2022|3.1k
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|1.6k
International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
|Blood|2015|1.2k